A federal judge has allowed Gilead Sciences to submit additional evidence in a drug-patent dispute with Merck, after Gilead claimed a former Merck patent attorney lied under oath in the case.
WSJ.com: Law, Wall Street Journal: Business: Law
Mon, 05/02/2016 - 4:27pm
A federal judge has allowed Gilead Sciences to submit additional evidence in a drug-patent dispute with Merck, after Gilead claimed a former Merck patent attorney lied under oath in the case.